Swedbank
VERA icon

Swedbank’s Vera Therapeutics VERA Stock Holding History

Swedbank’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-50,000
Closed -$2.15M – 723
2026
Q2 		$2.15M Buy
+50,000
New +$1.86M ﹤0.01% 646
2026
Q1 		– Sell
-121,200
Closed -$6.14M – 704
2025
Q4 		$6.14M Buy
121,200
+71,200
+142% +$2.53M 0.01% 552
2025
Q3 		$1.45M Buy
+50,000
New +$1.16M ﹤0.01% 629

Other funds holding VERA

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Swedbank's VERA Position: Q3 2026 in Review

Swedbank sold out of Vera Therapeutics (VERA) in Q3 2026, closing a stake of 50,000 shares — an estimated $2.15M sold.

Swedbank first reported a position in VERA in Q3 2025 and held it in 3 quarters. The position peaked at $6.14M in Q4 2025. 147 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

  • Swedbank reported no remaining Vera Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Swedbank sold 50,000 Vera Therapeutics shares in Q3 2026, an estimated $2.15M.
  • Swedbank first reported a position in Vera Therapeutics in Q3 2025 and held it in 3 quarters.
  • Swedbank's Vera Therapeutics position peaked at $6.14M in Q4 2025.
  • 147 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on Swedbank's 13F filing for Q3 2026, filed 27 Oct 2026.